Tianjin Chase Sun Pharmaceutical Co. Ltd. | Balance Sheet
Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
401
594
1,394
1,375
1,352
1,209
Total Accounts Receivable
686
1,038
1,808
2,024
1,815
1,997
Inventories
211
323
393
407
542
639
Other Current Assets
11
27
45
94
104
68
Total Current Assets
1,309
1,981
3,639
3,900
3,813
3,912
Net Property, Plant & Equipment
717
798
1,163
1,472
1,722
1,859
Total Investments and Advances
66
41
43
236
270
282
Long-Term Note Receivable
-
-
10
1
-
-
Intangible Assets
114
185
1,563
1,613
1,554
1,333
Other Assets
2
5
9
13
20
32
Total Assets
2,219
3,043
6,473
7,281
7,428
7,484
ST Debt & Current Portion LT Debt
63
360
465
615
286
Accounts Payable
157
103
199
179
200
Income Tax Payable
26
54
9
33
44
Other Current Liabilities
228
298
467
376
344
Total Current Liabilities
475
815
1,141
1,203
875
Long-Term Debt
19
-
5
-
-
Deferred Taxes
7
30
42
43
45
Total Liabilities
497
818
1,149
1,207
878
Common Equity (Total)
1,691
2,192
5,269
5,929
6,352
Total Shareholders' Equity
1,691
2,192
5,269
5,929
6,352
Total Equity
1,703
2,204
5,290
6,039
6,509
Liabilities & Shareholders' Equity
2,219
3,043
6,473
7,281
7,428
Accumulated Minority Interest
12
13
21
109
157
Non-Equity Reserves
19
21
34
36
41
About Tianjin Chase Sun Pharmaceutical Co.
View Profile
